# 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/4cps-070-evaluation-of-avoided-cost-in-clinical-trials-with-immunotherapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | L Escobar Hernández,O Ballesta López,JE Megias Vericat,T Palanques Pastor,N Benito Zazo,M. La Mar,María Tordera Baviera,JL Poveda Andrés |
| Citations | 2 |
| DOI | 10.1136/ejhpharm-2024-eahp.174 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ejhp.bmj.com/content/ejhpharm/31/Suppl_1/A85.2.full.pdf |
| OpenAlex ID | https://openalex.org/W4393005223 |
| Type | conference-paper |
| Year | 2024 |

## Paper authors

- [JL Poveda Andrés](https://scholariq.org/researchers/jl-poveda-andres/)

## Paper journal

- [Section 4: Clinical pharmacy services](https://scholariq.org/journals/section-4-clinical-pharmacy-services/)

## Paper primary topic

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Paper topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.